RESEARCHER PROFILE
Sara M. Elgazwi
S
University of Derna
Sara M. Elgazwi works in Synthesis and biological activity, Computational Drug Discovery Methods, Diabetes Management and Research, Natural product bioactivities and synthesis, Synthesis and Characterization of Heterocyclic Compounds. Recorded institutional associations include University of Derna.
9Publications
150Citations
5H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Novel series of 6-(2-substitutedacetamido)-4-anilinoquinazolines as EGFR-ERK signal transduction inhibitors in MCF-7 breast cancer cells
2018 · 60 citationsDesign and synthesis of pyrazolo[3,4-d]pyrimidines: Nitric oxide releasing compounds targeting hepatocellular carcinoma
2017 · 44 citationsCucurbitacins inspired organic synthesis: Potential dual inhibitors targeting EGFR – MAPK pathway
2019 · 25 citationsNovel NO-TZDs and trimethoxychalcone-based DHPMs: design, synthesis, and biological evaluation as potential VEGFR-2 inhibitors
2024 · 9 citationsStudy the Protective Effect of Ginger against the Toxicity of Dimethoate on Hormones in Rabbits
2021 · 6 citationsNovel EGFR‐MAPK kinase and ABC transporter inhibitors for HepG2 resistant to Erlotinib
2022 · 4 citationsStudy of Anti-proliferative Activity of Cucurbitacins Inspired Estrone Analogs on Hepatocellular Carcinoma
2018 · 2 citationsStudy the Role of Glycemic Index Values of Some Foods in the Type 2 Diabetes Mellitus Control
2025 · 0 citationsStudy the Effect of Vitamin D Supplementation on Children with Vitamin D Deficiency and Type 1 Diabetes Mellitus in Derna City
2023 · 0 citations
